glp-1 receptor agonist diarrhea management Repurposing glucagon-like peptide-1 agonists for the treatment of neurodegenerative disorders Evolution of GLP‐1 Receptor Agonists

10.1046/j.1365-201x.2003.01093.x 20 Guerrero-OchoaP.Aguilar-MachadoD.Ibez-PrezR.Macas-LenJ.Hurtado-GuerreroR.RasoJ.et al (2020)

INGREDIENTS Glycerin (Coconut Derived), Medium Chain Triglycerides (Coconut Derived), Oleic Acid (From Olive Oil), Glutathione, Lactoferrin (Milk), Phosphatidylcholine, Natural Flavours (Orange Peel, Cinnamon Oil (bark), Clove Oil, Vanilla Extract), Vitamin E (as D Alpha Tocopherol), Stevia (Rebaudioside-A), Riboflavin and Meolybdenum

Several animal studies have also suggested that TMAO may be a risk factor for insulin resistance and diabetes

Zheng S, Que X, Wang S et al (2023) ZDHHC5-mediated NLRP3 palmitoylation promotes NLRP3-NEK7 interaction and inflammasome activation